Galleon Pharmaceuticals
Horsham, Pennsylvania, United States
About Galleon Pharmaceuticals
Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $53.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2015)
- Website: galleonpharma.com
- Phone: (267)803-1970
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/galleon-pharmaceuticals-2496549 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.